Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Global Biomedical Sensors Market - Expected to Reach a Value of USD 18.4 Billion by 2022
By: PR Newswire Association LLC. - 18 Sep 2017Back to overview list

DUBLIN, September 18, 2017 /PRNewswire/ --

The "Global Biomedical Sensors Market - By Type , Industry, Application, Geography, Trends, Forecast - 2017 - 2022" report has been added to Research and Markets' offering.

The global biomedical sensors market was valued at USD 12.96 billion in 2016 and is expected to reach a value of USD 18.44 billion by the end of 2022, growing at a projected CAGR of 6.05%.

Technological advancements in the field of biomedical sensors using microtechnology and nanotechnology will bring tiny, robust, smart and cost-effective sensors that are adaptable to the individual genetic formulation. These sensors can be set to trigger alerts when they enlist unpredictable readings, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. Investments in developing sensors with such capabilities will act as a major factor for the growth of the market and eventually these products will find huge demand in the healthcare industry.

Utility in the hazardous environments and geographical locations which are susceptible to natural disasters will drive the biomedical sensors market. Increased demand from the healthcare industry to monitor patients with diabetic and heart conditions will further boost the growth of the market. Early detection of irregularities in the health status of the patients along with necessary medical attention will contribute to the better quality of life.

Even though biomedical sensors are playing a major role in life-saving situations, the market faces certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption.

Companies Mentioned:

  • GE Healthcare
  • Honeywell International Inc.
  • Stmicroelectronics N.V.
  • First Sensor AG
  • Medtronic PLC
  • Smiths Medical
  • Measurement Specialties, Inc.
  • Analog Devices, Inc.
  • Texas Instruments
  • NXP Semiconductor N.V.
  • LumaSense Technologies
  • Zephyr Technology Corp.
  • Nonin Medical Inc.
  • Others

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

5. Technology Snapshot

6. Global Biomedical Sensors Market Segmentation - Market Share, Trends, Forecast (2016-2021)

7. Vendor Market Share Analysis

8. Competitive Landscape - Company Profiles

9. Investment Analysis

10. Future of Global Biomedical Sensors Market

For more information about this report visit https://www.researchandmarkets.com/research/z7k26r/global_biomedical

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



View original content:http://www.prnewswire.com/news-releases/global-biomedical-sensors-market---expected-to-reach-a-value-of-usd-184-billion-by-2022-300520567.html

SOURCE Research and Markets

Related companies:Ascendiant Capital | RBC Capital Market | KeyBanc Capital Markets
Copyright 2017 PR Newswire Association LLC. Back to overview list
to the top ↑